Skadden Advises Endo On $223M HealthTronics Deal
Continuing its push into the urological health market, Endo Pharmaceuticals Inc. announced that it had agreed to buy HealthTronics Inc. in an approximately $223 million all-cash deal....To view the full article, register now.
Already a subscriber? Click here to view full article